Final answer:
IVIG and aspirin are administered to children with Kawasaki disease to reduce the risk of coronary artery abnormalities, with IVIG serving to dampen immune activity and aspirin providing anti-inflammatory and antiplatelet effects.
Step-by-step explanation:
True: IVIG (Intravenous Immunoglobulin) and aspirin are indeed given to reduce the risk of coronary artery abnormalities in children diagnosed with Kawasaki disease. Kawasaki disease is an acute febrile illness of unknown etiology that primarily affects children younger than 5 years of age. It is the leading cause of acquired heart disease among children in developed countries.
IVIG is administered to reduce inflammation and decrease the immune system's activity. Aspirin, on the other hand, is given for its anti-inflammatory and antipyretic effects, and in the context of Kawasaki disease, it is also used for its antiplatelet properties, which are believed to help prevent coronary artery thrombosis.
For Kawasaki disease treatment, the standard approach includes a high dose of IVIG and aspirin to decrease inflammation and the risk of developing coronary artery aneurysms, which can be a serious complication of the disease.